Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-18

Clinical Trial Update: Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing erythromycin versus azithromycin for preterm prelabor rupture of membranes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • ERYTHROMYCIN (ERYTHROMYCIN)

Snippet

Sponsor: Inova Health Care Services | Conditions: Premature Rupture of Membrane | Phase 3 | Status: RECRUITING